SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base ...
A groundbreaking Cleveland Clinic trial is demonstrating how gene-editing technology could transform the way millions of Americans manage high cholesterol. A Phase 1 clinical trial at Cleveland Clinic ...
A groundbreaking gene-editing treatment is showing promise as a one-off solution for high cholesterol, potentially reducing heart disease risk. Early trials in a small number of people have ...
Cardiovascular disease is the world’s leading killer and one of the most economically damaging, as its prevalence and costs have been rising. According to our research, offering a one-time ...
Lowering cholesterol is one of the most effective ways to reduce your risk of heart disease, and it may soon be possible to get a one-and-done gene therapy to keep cholesterol and triglyceride levels ...
The U.S. Food and Drug Administration (FDA) on Friday announced that it has approved Casgevy, the first CRISPR gene-editing therapy for sickle cell disease, paving the way for thousands of patients in ...
Scientists achieved a genetic breakthrough by removing an extra human chromosome using gene-editing technology. This landmark study successfully deleted the surplus chromosome 21 responsible for Down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results